Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy of Varying Concentrations of Methylene Blue Combined With Ropivacaine for Postoperative Analgesia Following Milligan-Morgan Hemorrhoidectomy: A Single-Center, Prospective, Open-Label, Randomized, Parallel-Controlled Trial

NCT07164807 is registered in ClinicalTrials.gov with The Affiliated Hospital of Putian University as lead sponsor.

NCT NCT07164807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07164807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy of Varying Concentrations of Methylene Blue Combined With Ropivacaine for Postoperative Analgesia Following Milligan-Morgan Hemorrhoidectomy: A Single-Center, Prospective, Open-Label, Randomized, Parallel-Controlled Trial
Lead sponsor
The Affiliated Hospital of Putian University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 30, 2025
Completion date
December 31, 2026
Enrollment
177 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methylene blue, milligan-morgan hemorrhoidectomy, mixed hemorrhoids